Key result
Screening echocardiography in low-risk pregnant women in Western Kenya identified a point prevalence of rheumatic heart disease-associated cardiac lesions of 5.0 per 1,000 (95% CI 1.0-14.5).
Why the study?
Rheumatic heart disease in sub-Saharan Africa contributes to significant cardiac morbidity and mortality, yet prevalence estimates of RHD lesions in pregnancy are lacking.
What is the prevalence of RHD and other cardiac lesions detected by screening echocardiography in low-risk pregnant women in Kenya?
Cross-Sectional (n=601)
No
What is the prevalence of RHD and other cardiac lesions detected by screening echocardiography in low-risk pregnant women in Kenya?
Screening echocardiography in a low-risk pregnant population in Kenya identified a moderately high prevalence of clinically relevant cardiac lesions, demonstrating feasibility and high patient acceptability.
Screening echocardiography detects RHD in 5/1000 low-risk Kenyan pregnancies; leaves open whether routine use improves maternal outcomes in endemic regions.
Background: Rheumatic heart disease (RHD) in sub-Saharan Africa contributes to significant cardiac morbidity and mortality, yet prevalence estimates of RHD lesions in pregnancy are lacking. Objectives: Our first aim was to evaluate women using echocardiography to estimate the prevalence of RHD and other cardiac lesions in low-risk pregnancies. Our second aim was to assess the feasibility of screening echocardiography and its acceptability to patients. Methods: We prospectively recruited 601 pregnant women from a low-risk antenatal clinic at a tertiary care maternity centre in Western Kenya. Women completed a questionnaire about past medical history and cardiac symptoms. They underwent standardized screening echocardiography to evaluate RHD and non-RHD associated cardiac lesions. Our primary outcome was RHD-associated cardiac lesions and our secondary outcome was a composite of any clinically-relevant cardiac lesion or echocardiography finding. We also recorded duration of screening echocardiography and its acceptability among pregnant women in this sample. Results: The point prevalence of RHD-associated cardiac lesions was 5.0/1,000 (95% confidence interval: 1.0-14.5), and the point prevalence of all clinically significant lesions/findings was 21.6/1,000 (11.6-36.7). Mean screening time was seven minutes (SD 1.7, range: 4-17) for women without cardiac abnormalities and 13 minutes (SD 4.6, range: 6-23) for women with abnormal findings. Echocardiography was acceptable to women with 74.2% agreeing to participate. Conclusions: The prevalence of clinically-relevant cardiac lesions was moderately high in a low-risk population of pregnant women in Western Kenya.
No takes yet. Share an insight, caveat, or question.
Snelgrove et al. (2021) conducted a cross-sectional in Low-risk pregnancy (n=601). Screening echocardiography was evaluated on RHD-associated cardiac lesions (95% CI 1.0-14.5). Screening echocardiography in low-risk pregnant women in Western Kenya identified a point prevalence of rheumatic heart disease-associated cardiac lesions of 5.0 per 1,000 (95% CI 1.0-14.5).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: